Effects of Mini-Dystrophin on Dystrophin-Deficient, Human Skeletal Muscle-Derived Cells

Background: We are developing a novel therapy for Duchenne muscular dystrophy (DMD), involving the transplantation of autologous, skeletal muscle-derived stem cells that have been genetically corrected to express dystrophin. Dystrophin is normally expressed in activated satellite cells and in differ...

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, Jinhong, Counsell, John, Morgan, Jennifer E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7582244/
https://www.ncbi.nlm.nih.gov/pubmed/32998454
http://dx.doi.org/10.3390/ijms21197168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7582244/
https://www.ncbi.nlm.nih.gov/pubmed/32998454
http://dx.doi.org/10.3390/ijms21197168

Ejemplares similares